Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from TrivarX Limited ( (AU:TRI) ).
TrivarX Limited has issued 8,767,123 ordinary fully paid shares at $0.0219 per share to settle outstanding director fees, as announced under section 708A of the Corporations Act. This move, authorized by the Board of Directors, indicates compliance with relevant legal provisions and suggests a strategic financial management approach, potentially impacting the company’s financial standing and stakeholder interests.
More about TrivarX Limited
TrivarX Limited is a mental health technology company that focuses on using objective measures to aid in the early detection and screening of mental health conditions. Founded in Australia, the company operates from offices in Perth and Minneapolis and is listed on the Australian Securities Exchange and trades on the OTCQB Venture Market.
YTD Price Performance: 43.75%
Average Trading Volume: 3,368,163
Technical Sentiment Signal: Hold
Current Market Cap: A$16.27M
See more insights into TRI stock on TipRanks’ Stock Analysis page.